Bayer and Kumquat initiate Phase I study with KRAS G12D inhibitor in patients with KRAS-mutated tumors
First patients enrolled in Phase I trial with KQB548, an investigational KRAS inhibitor designed to treat KRAS G12D-mutated tumors
First patients enrolled in Phase I trial with KQB548, an investigational KRAS inhibitor designed to treat KRAS G12D-mutated tumors
New study presents a human-relevant stress model for assessing potential therapeutics
New infrastructure makes it possible for healthcare organizations to integrate AI agents seamlessly into critical workflows like benefit verification and prior authorization
Collaboration combines Lunit's AI expertise with Agilent's diagnostic leadership to revolutionize biomarker testing and enhance precision medicine capabilities
Philips and Masimo will also collaborate on the development and co-promotion of next-generation monitoring solutions
Rhonda Pacheco to succeed Julie Kim, who was appointed to be Takeda’s next CEO
The HCl gas is generated continuously which is absorbed in the water scrubber using a chilled falling film system
Breakthrough UNITY 4D Phaco delivers up to 2X faster nucleus removal and 41% less energy into the eye
He has been associated with the Zydus Group since 2009
Subscribe To Our Newsletter & Stay Updated